Thermo Fisher Scientific Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Marc N. Casper
- Full Time Employees
- 125,000
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 168 Third Avenue Waltham MA United States of America 02451
- IPO Date
- Mar 17, 1980
- CIK
- 0000097745
- Website
- thermofisher.com
- Similar Companies
- Business
- Thermo Fisher Scientific Inc. (NYSE: TMO) provides analytical instruments, equipment, software, services, consumables, and reagents for research, analysis, discovery, and diagnostics worldwide. The company offers products including mass spectrometry systems, chromatography instruments, genetic analysis tools, bioprocessing equipment, clinical diagnostics assays, laboratory automation solutions, and electron microscopy technologies; its key brands encompass Thermo Scientific, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon. Headquartered in Waltham, Massachusetts, Thermo Fisher was originally founded in 1902 through the merger of Fisher Scientific and Thermo Electron in 2006, and operates in over 70 countries serving pharmaceutical, biotechnology, academic, government, and healthcare customers across life sciences, analytical technologies, specialty diagnostics, and laboratory products segments. Recently, the company expanded its capabilities through the acquisition of Olink Holding AB in 2024 to bolster proteomics offerings, launched the new Orbitrap Astral mass spectrometer in late 2024 for high-throughput proteomics, and formed strategic partnerships including a multi-year collaboration with AstraZeneca to advance biomarker discovery; in 2025, Thermo Fisher announced expansions in gene editing technologies and sustainable manufacturing initiatives amid ongoing supply chain optimizations.
Company News
Should You Continue to Hold TMO Stock in Your Portfolio?
‘Corporate America Is Basically Exterminating Your Career." Clark Howard’s Sounds Alarm For Americans In Their 50s, Who Want To Work Till 65
Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More
Why Moderna's Cancer Vaccine Matters to Investors
Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis
TMO Stock Could Gain Following the Launch of EMPAD G2 Detector
37,709 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by Beacon Pointe Advisors LLC
Ausdal Financial Partners Inc. Makes New $456,000 Investment in Thermo Fisher Scientific Inc. $TMO
Bank OZK Takes $1.10 Million Position in Thermo Fisher Scientific Inc. $TMO
Thermo Fisher Scientific Introduces the Thermo Scientific™ EMPAD™ G2 Electron Detector to Advance Materials Research
Delta Air, Target, Thermo Fisher Scientific And A Financial Stock On CNBC's ‘Final Trades'
Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis, Enabling More Labs to Decode the Story Behind a Sample
Is TMO Overvalued? DCF Says Worth $491
Avanda Investment Management Pte. Ltd. Invests $2 Million in Thermo Fisher Scientific Inc. $TMO
Allworth Financial LP Takes $12.20 Million Position in Thermo Fisher Scientific Inc. $TMO
Bank of New York Mellon Corp Invests $1.97 Billion in Thermo Fisher Scientific Inc. $TMO
Advisors Capital Management LLC Makes New Investment in Thermo Fisher Scientific Inc. $TMO
3,366 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by BOK Financial Private Wealth Inc.
Act Two Investors LLC Acquires New Shares in Thermo Fisher Scientific Inc. $TMO
BlackRock Inc. Takes $15.50 Billion Position in Thermo Fisher Scientific Inc. $TMO